ArticleApoptosis : an international journal on programmed cell death2025
KAT2A alleviates the glucose starvation-induced mitochondrial oxidative stress and ferroptosis to promote colon cancer progression.
Article in Apoptosis : an international journal on programmed cell death, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Safety evaluation of Sodium-glucose cotransporter 2 inhibitors for cancer risk in specific populations: systematic review and meta-analysis.Frontiers in clinical diabetes and healthcare · 2026Pooled it
- Synergistic anticancer effects of cabozantinib and cuproptosis induction driven by DHRS2-KAT2A-H3K27ac axis in clear cell renal cell carcinoma.Biology direct · 2026Article
- In vitro experiments and bioinformatic analyses implicate KAT2A in the occurrence and development of hepatocellular carcinoma.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Beyond its established role as a lysine acetyltransferase, KAT2A has recently been identified to possess succinyltransferase activity. This study aims to investigate the function of KAT2A in mediating succinylation modification of heat shock protein 60 (HSP60) and to elucidate the underlying mechanism through which KAT2A regulates mitochondrial oxidative stress and ferroptosis induced by glucose starvation in colon cancer cells via HSP60 succinylation. Bioinformatic analyses were conducted to assess KAT2A expression in colon cancer and its association with patient prognosis. Protein interaction between KAT2A and HSP60 was examined by co-immunoprecipitation (Co-IP). Intracellular Fe²⁺ levels, lipid peroxidation, and mitochondrial reactive oxygen species (mtROS) were measured using FerroOrange, C11 BODIPY 581/591, and MitoSOX Red fluorescent probes, respectively. Mitochondrial localization and membrane potential were evaluated via immunofluorescence assays. KAT2A is upregulated in colon cancer and correlates with poor prognosis, largely attributable to its ability to enhance cell viability and invasion under glucose deprivation. Overexpression of KAT2A conferred resistance to glucose starvation-induced ferroptosis by mediating HSP60 succinylation. Label-free quantitative proteomic analysis identified three critical succinylation sites on HSP60 (K72, K133, K191), with K191 being the principal site regulating ferroptosis. Succinylated HSP60 interacts with GSTK1 and promotes the mitochondrial translocation of the HSP60-GSTK1 complex, mitigating mitochondrial oxidative stress under glucose starvation. Through this mechanism, KAT2A suppresses ferroptosis and supports colon cancer cell survival and tumor growth. The KAT2A-HSP60-GSTK1 axis attenuates glucose starvation-induced mitochondrial oxidative stress, thereby inhibiting ferroptosis and promoting tumor progression in colon cancer.
Indexed as
Identifiers
41100000What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.